TY - JOUR
T1 - A 21-year experience with major hemorrhage after percutaneous liver biopsy
AU - McGill, Douglas B.
AU - Rakela, Jorge
AU - Zinsmeister, Alan R.
AU - Ott, Beverly J.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1990/11
Y1 - 1990/11
N2 - Nine thousand two hundred twelve liver biopsies were performed according to a defined protocol, and data were prospectively recorded to identify risk factors for major bleeding. There were 10 fatal and 22 nonfatal hemorrhages (0.11% and 0.24%, respectively). By comparison with a control group that did not hemorrhage, malignancy, age, sex, and the number of passes were the only predictable risk factors. The risk of fatal hemorrhage in patients with malignancy is estimated to be 0.4%; for nonfatal hemorrhage, 0.57%. In patients undergoing liver biopsy for nonmalignant disease, the risks are 0.04% and 0.16%, respectively.
AB - Nine thousand two hundred twelve liver biopsies were performed according to a defined protocol, and data were prospectively recorded to identify risk factors for major bleeding. There were 10 fatal and 22 nonfatal hemorrhages (0.11% and 0.24%, respectively). By comparison with a control group that did not hemorrhage, malignancy, age, sex, and the number of passes were the only predictable risk factors. The risk of fatal hemorrhage in patients with malignancy is estimated to be 0.4%; for nonfatal hemorrhage, 0.57%. In patients undergoing liver biopsy for nonmalignant disease, the risks are 0.04% and 0.16%, respectively.
UR - http://www.scopus.com/inward/record.url?scp=0025119535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025119535&partnerID=8YFLogxK
U2 - 10.1016/0016-5085(90)91167-5
DO - 10.1016/0016-5085(90)91167-5
M3 - Article
C2 - 2101588
AN - SCOPUS:0025119535
SN - 0016-5085
VL - 99
SP - 1396
EP - 1400
JO - Gastroenterology
JF - Gastroenterology
IS - 5
ER -